183 filings
Page 4 of 10
8-K
bvce1tt
16 Nov 11
Regulation FD Disclosure
12:00am
8-K
v4ydd
16 Nov 11
Departure of Directors or Certain Officers
12:00am
8-K
jtozq2t60uyq
14 Nov 11
Other Events
12:00am
8-K
zk6652
9 Nov 11
Unigene Reports Third Quarter 2011 Financial Results
12:00am
8-K
4qm8z be2b
9 Nov 11
Regulation FD Disclosure
12:00am
8-K
7c1f9ffodcruowm3 b7
9 Nov 11
Unigene Announces Positive Top-Line Results of Phase 2 Oral PTH Study for the Treatment of Osteoporosis in Postmenopausal Women
12:00am
8-K
9v7fwdqnx39z2pf45
2 Nov 11
Departure of Directors or Certain Officers
12:00am
8-K
igu4aruof 27u
20 Oct 11
Unigene Completes All Patient Dosing in Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women
12:00am
8-K
3soyuw57
13 Oct 11
Other Events
12:00am
8-K
9216tgzr9i0nic
6 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
kpf7099fwf
6 Oct 11
Regulation FD Disclosure
12:00am
8-K
pofcqjvpx5asfm r7lq8
6 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
w2s8vfadghi3e 69
21 Sep 11
Other Events
12:00am
8-K
vh4cikikcyc41 sxn
19 Sep 11
Other Events
12:00am
8-K
bb623g bll3xd
12 Sep 11
Regulation FD Disclosure
12:00am
8-K
vwzbnsw lk
7 Sep 11
Unigene Appoints Industry Veteran Theron (Ted) Odlaug as New Independent Director to Board
12:00am
8-K
bepy56j
30 Aug 11
Other Events
12:00am
8-K
dds02ingvc96q69qqq
9 Aug 11
Regulation FD Disclosure
12:00am
8-K
1o0uybu sjzb1
8 Aug 11
Unigene Reports Second Quarter 2011 Financial Results
12:00am
8-K
1v1jze9
8 Aug 11
Entry into a Material Definitive Agreement
12:00am